| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.02▲ | 2.02▲ | 2.03▼ | 2.03▲ | 2.00▲ |
| MA10 | 2.02▼ | 2.03▼ | 2.03▼ | 2.06▼ | 1.82▲ |
| MA20 | 2.03▼ | 2.03▼ | 2.03▼ | 2.00▲ | 1.76▲ |
| MA50 | 2.02▼ | 2.05▼ | 2.07▼ | 1.81▲ | 1.84▲ |
| MA100 | 2.05▼ | 2.06▼ | 2.02▼ | 1.76▲ | 2.10▼ |
| MA200 | 2.06▼ | 1.95▲ | 1.85▲ | 1.80▲ | 2.11▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.001▼ | 0.000▲ | -0.011▼ | 0.052▲ |
| RSI | 46.372▼ | 45.491▼ | 45.595▼ | 59.546▲ | 61.178▲ |
| STOCH | 17.500▼ | 27.870 | 47.778 | 26.678 | 68.899 |
| WILL %R | -80.000▼ | -80.000▼ | -66.667 | -66.667 | -34.783 |
| CCI | -44.422 | -86.174 | -86.822 | -28.930 | 109.204▲ |
|
Friday, October 10, 2025 01:24 PM
Analyst discuss the evolving landscape in Non-Small Cell Lung Cancer (NSCLC) (relevant companies SMMT TIL CBIO IMMP NVLT) on an Analyst/Industry conference call to be held on October 19. Take ...
|
|
Thursday, October 09, 2025 08:24 AM
Immutep (IMMP) announces a patient enrolment update for the TACTI-004 Phase III trial evaluating eftilagimod alfa in combination with MSD’s (MRK) anti-PD-1 therapy KEYTRUDA and chemotherapy as first ...
|
|
Thursday, October 09, 2025 01:00 AM
SYDNEY, AUSTRALIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/10/25 | 2.03 | 2.08 | 2.00 | 2.04 | 136,069 |
| 24/10/25 | 2.03 | 2.08 | 2.00 | 2.04 | 61,417 |
| 23/10/25 | 1.96 | 2.07 | 1.96 | 2.01 | 127,498 |
| 22/10/25 | 2.05 | 2.09 | 1.97 | 2.00 | 221,550 |
| 21/10/25 | 2.07 | 2.09 | 2.03 | 2.06 | 135,253 |
| 20/10/25 | 2.07 | 2.17 | 2.035 | 2.04 | 371,997 |
| 17/10/25 | 2.08 | 2.10 | 2.0208 | 2.07 | 131,038 |
| 16/10/25 | 2.16 | 2.28 | 2.0694 | 2.10 | 357,638 |
| 15/10/25 | 2.10 | 2.25 | 2.10 | 2.12 | 311,400 |
| 14/10/25 | 2.09 | 2.09 | 1.9694 | 2.09 | 315,656 |
|
|
||||
|
|
||||
|
|